Jonathan Lopez

ORCID: 0000-0003-3768-2378 · 2 papers in corpus

2024

Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.

Nature communications ·doi:10.1038/s41467-024-45974-w

Most patients with advanced ovarian cancer (AOC) ultimately relapse after platinum-based chemotherapy. Combining bevacizumab, olaparib, and durvalumab likely drives synergistic activity. This open-label phase 2 study (NCT04015739) aimed to …

article 2021

Evidence for Beneficial Effects of Voluntary Exercise in an Endometriosis‐Stress Animal Model

·doi:10.1096/fasebj.2021.35.s1.01956

Endometriosis is a chronic gynecological disorder characterized by peritoneal inflammation, infertility, chronic pelvic pain, fibrosis, and growth of endometrial tissue outside the endometrial cavity. In previous studies we found that expos…